COVID-19 Prevention Network Community Engagement Strategy Webinar
The COVID-19 Prevention Network (CoVPN) was established by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to enroll thousands of volunteers for large-scale Phase 3 clinical trials testing a variety of investigational vaccines and monoclonal antibodies to protect people from COVID-19. As COVID-19 is impacting entire communities with a disproportionate effect on communities of color, diverse community participation in vaccine trials is at the heart of the CoVPN.
As part of the commitment to meaningful community engagement, the CoVPN has developed a strategic plan to provide an overview of strategies and efforts, which involves developing tools and materials for potential participants, clinical trials sites, and community education programs focused on engaging stakeholder groups to ensure that communities have the resources they need to make informed decisions.
Join us today at 12 PM Eastern/9 AM Pacific for a conversation with our panelists to learn more about the ways the COVID-19 Prevention Network is engaging Black, Latinx, and Indigenous communities around COVID-19 and vaccine science.
Moderator:
Mia Keeys, MA
Director of Health Policy and Advocacy, American Medical Association
Panelists:
Ulysses Burley, MD
CoVPN Faith Initiative Ambassador and Founder, UBtheCURE, LLC
Stephaun Wallace, PhD, MS
CoVPN & HIV Vaccine Trials Network (HVTN) Director of External Relations and Community Engagement
Danielle Campbell, MPH
CoVPN Community Working Group Member
Event Details
October 23, 2020 at 12:00pm EST - 1:00pm EST
Please submit questions to Keiko Purnell at kpurnell@nmqf.org. We also welcome suggestions for future webinar topics, as we plan to host more very soon!
